Increased Risk of Post-Thrombolysis Intracranial Hemorrhage in Acute Ischemic Stroke Patients with Leukoaraiosis: A Meta-Analysis.
BACKGROUND
Leukoaraiosis is common in patients with acute ischemic stroke. The results from many studies investigating the association between leukoaraiosis and intracranial hemorrhage after thrombolysis remain conflicting.


METHODS
A meta-analysis was performed to compare the risk of post-thrombolytic intracranial hemorrhage in patients with and without leukoaraiosis. Relevant reports were identified by searching PubMed, EmBase, Cochrane Library, and ISI Web of Science through December 2015 using a combination of subjective and random terms. Eligible studies that were original articles with a clear definition of leukoaraiosis and intracranial hemorrhage were selected and analyzed. Funnel plots, Egger's test, and Begg's test were conducted to assess the publication bias. Sensitivity analysis was also performed to evaluate the influence of each individual study.


RESULTS
Eleven trials that enrolled 6912 participants were included. There was a significantly increased risk for acute ischemic stroke patients with leukoaraiosis (odds ratio: 1.89, 95% confidence interval 1.51-2.37, P<0.001). Low heterogeneity and less publication bias was detected among these studies. The results of both computed tomography and magnetic resonance imaging performed on the subgroups of leukoaraiosis were significant. Furthermore, an association between leukoaraiosis and symptomatic intracranial hemorrhage was also confirmed. The odds ratios remained stable with no obvious variations on the sensitivity analysis. The limitations consisted of types of including trials and not matching some baseline variables.


CONCLUSIONS
The results of this meta-analysis show that leukoaraiosis approximately doubles the incidence of intracranial hemorrhage after thrombolytic therapy. However, it does not critically affect decision making regarding thrombolysis for patients with acute ischemic stroke. Additional investigations are required.
Department of Neurology, The Sixth Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Qianqian
Q
Lin
Department of Neurology, The Sixth Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Zhong
Z
Li
Department of Neurology, The Sixth Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Rui
R
Wei
Department of Neurology, The Sixth Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Qingfeng
Q
Lei
Department of Neurology, The Sixth Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Yunyun
Y
Liu
Department of Neurology, The Sixth Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Xiaodong
X
Cai
D002545:Brain Ischemia / Q000150:complications*; D006801:Humans; D020300:Intracranial Hemorrhages / Q000209:etiology*; D049292:Leukoaraiosis / Q000150:complications*; D012306:Risk; D020521:Stroke / Q000150:complications* / Q000628:therapy*; D015912:Thrombolytic Therapy / Q000009:adverse effects*